Myastenia Gravis Flashcards
General in myasthenia
Neuro muscular disease
It presents with weakness and fatigue
The prevalence is one in 10,000 to one in 50,000 and it affects twice as many women as men
Thymectomy results in remission of 35% of patients and improvement in 50% of patients
Signs and symptoms of myasthenia
Ocular muscle weakness resulting in Diplopia and ptosis
Difficulty in chewing or talking
Respiratory muscle weakness
Effects of pregnancy on MG
1/3 women get better
1/3 get worse
1/3 stay the same
Risk of deterioration highest if diagnosed within the last 12 months
30% women have exarcerbation post partum
Disease can be precipitated by (in myasthenia)
Emotional stress or anxiety
Intercurrent infections
Increased temperature
Sub therapeutic levels of medication caused by pregnancy changes
Effects of MG on pregnancy and labour
No change to pregnancy
It affects striated muscles so Ist stage I labour ok ; 2nd stage of labour may become a problem
Neonatal MG
Transient 9-20% babies
Poor sucking
Feeble cry
Generalised hypotonia
Swallowing difficulties
Facial paresis
Respiratory depression
Complete recovery within 2 months
Arthrogryposis multiplex congenital
Congenital joints contractures
Reduced fetal movements in utero
Some infants survive, some die in utero or in the neonatal period for pulmonary hypoplasia
High risk of recurrence
Antepartum care for myasthenia
MDT
continue anticholinesterase meds - increased doses or reduction of dose interval may be appropriate
Treat any infection aggressively
Anaesthetic assessment - more resistant to suxamethonium; more sensitive to non depolarising muscle relaxants. Narcosis can cause muscle fatigue
Magnesium sulphate can precipitate a crisis
Corticosteroids, immunosuppressants and plasmapheresis may be necessary in pregnancy
Intrapartum care for myasthenia
Administer anticholinesterase parentally to ensure adequate absorption
Aim for vaginal delivery but may require instrumental to avoid exhaustion
C/s for obstetric reasons only
Breastfeeding and myasthenia
Receptor antibodies pass in breast milk and may potentiate neonatal MG
drugs pass in milk and may cause gastrointestinal upset in the newborn